Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection.

von Felden, Johann; Schulze, Kornelius; Krech, Till; Ewald, Florian; Nashan, Björn; Pantel, Klaus; Lohse, Ansgar W; Riethdorf, Sabine; Wege, Henning

von Felden, Johann; Schulze, Kornelius; Krech, Till; Ewald, Florian; Nashan, Björn; Pantel, Klaus; Lohse, Ansgar W; Riethdorf, Sabine; Wege, Henning.

Afiliação

von Felden J; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Schulze K; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Krech T; Institute of Pathology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Ewald F; Department for Hepatobiliary and Transplant Surgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Nashan B; Department for Hepatobiliary and Transplant Surgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Pantel K; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Lohse AW; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Riethdorf S; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Wege H; Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Oncotarget ; 8(52): 89978-89987, 2017 Oct 27.

Article em En | MEDLINE | ID: mdl-29163804

Palavras-chave

BCLC A; CTC; hepatocellular carcinoma; liquid biopsy; precision medicine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google